Stefanie Zschäbitz

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

Neeraj Agarwal, Arun Azad, Joan Carles et al. · The Lancet · 2023 · 453 citations

Urology, Medicine, Pharmacology +5

First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

Karim Fizazi, Arun Azad, Nobuaki Matsubara et al. · Nature Medicine · 2023 · 113 citations · Full text

<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz et al. · Journal of Clinical Oncology · 2024 · 95 citations · Full text

B vitamin intakes and incidence of colorectal cancer: results from the Women’s Health Initiative Observational Study cohort

Stefanie Zschäbitz, Ting‐Yuan David Cheng, Marian L. Neuhouser et al. · American Journal of Clinical Nutrition · 2012 · 86 citations · Full text

Nutrition, Nutritional Epidemiology, Oncology +15

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

Georg Martin Haag, Christoph Springfeld, Barbara Grün et al. · European Journal of Cancer · 2022 · 86 citations

Medicine, Immunology, Pathology +7